Express News | Tempest Receives Orphan Drug Designation From the U.S. Food and Drug Administration for Amezalpat to Treat Patients With Hepatocellular Carcinoma (Hcc)
Tempest Receives Orphan Drug Designation From the U.S. Food and Drug Administration for Amezalpat to Treat Patients With Hepatocellular Carcinoma (HCC)
Tempest Therapeutics' PPARalpha Inhibitor Receives FDA Orphan Designation
Express News | Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WeatherFlow-Tempest Secures $3 Million in Growth Capital to Accelerate Innovation in Weather Technology
MRILIU : This trend is a complete waste of time, continue tomorrow.
小竜 OP MRILIU : Patience will get paid